Is Agilon Health Stock a Good Investment?
Agilon Health Investment Advice | AGL |
- Examine Agilon Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Agilon Health's leadership team and their track record. Good management can help Agilon Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Agilon Health's business and its evolving consumer preferences.
- Compare Agilon Health's performance and market position to its competitors. Analyze how Agilon Health is positioned in terms of product offerings, innovation, and market share.
- Check if Agilon Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Agilon Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in agilon health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if agilon health is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Excited | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Agilon Health Stock
Researching Agilon Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company shares are held by institutions such as insurance companies. The book value of Agilon Health was presently reported as 1.4. The company has Price/Earnings To Growth (PEG) ratio of 0.19. agilon health recorded a loss per share of 0.76. The entity last dividend was issued on the February 17, 2016. The firm had 2:1 split on the December 4, 1995.
To determine if Agilon Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Agilon Health's research are outlined below:
| agilon health is way too risky over 90 days horizon | |
| agilon health appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 4.32 B. Reported Net Loss for the year was (262.8 M) with loss before taxes, overhead, and interest of (51.77 M). | |
| agilon health has about 497.07 M in cash with (156.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32. | |
| agilon health has a poor financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: agilon health Trading Up 8.5 percent Following Analyst Upgrade - MarketBeat |
Agilon Health Quarterly Cost Of Revenue |
|
Agilon Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in agilon health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Agilon Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Agilon Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Agilon Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-05-05 | 2022-03-31 | -0.0006 | 0.0029 | 0.0035 | 583 | ||
2024-08-06 | 2024-06-30 | -0.08 | -0.07 | 0.01 | 12 | ||
2023-08-03 | 2023-06-30 | -0.03 | -0.04 | -0.01 | 33 | ||
2021-10-28 | 2021-09-30 | -0.1 | -0.09 | 0.01 | 10 | ||
2023-11-02 | 2023-09-30 | -0.06 | -0.08 | -0.02 | 33 | ||
2023-05-09 | 2023-03-31 | 0.02 | 0.04 | 0.02 | 100 | ||
2022-11-03 | 2022-09-30 | -0.05 | -0.07 | -0.02 | 40 | ||
2021-05-26 | 2021-03-31 | -0.03 | -0.05 | -0.02 | 66 |
Agilon Health Target Price Consensus
Agilon target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Agilon Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 23 | Buy |
Most Agilon analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Agilon stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of agilon health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAgilon Health Target Price Projection
Agilon Health's current and average target prices are 3.59 and 2.89, respectively. The current price of Agilon Health is the price at which agilon health is currently trading. On the other hand, Agilon Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Agilon Health Market Quote on 30th of January 2025
Target Price
Analyst Consensus On Agilon Health Target Price
Agilon Health Analyst Ratings
Agilon Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Agilon Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Agilon Health's financials, market performance, and future outlook by experienced professionals. Agilon Health's historical ratings below, therefore, can serve as a valuable tool for investors.Know Agilon Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Agilon Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading agilon health backward and forwards among themselves. Agilon Health's institutional investor refers to the entity that pools money to purchase Agilon Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Goldman Sachs Group Inc | 2024-09-30 | 5.7 M | Bank Of America Corp | 2024-09-30 | 5 M | Charles Schwab Investment Management Inc | 2024-09-30 | 3 M | Northern Trust Corp | 2024-09-30 | 2.6 M | Millennium Management Llc | 2024-09-30 | 2.5 M | Citadel Advisors Llc | 2024-09-30 | 2.1 M | Deutsche Bank Ag | 2024-09-30 | 2.1 M | Citigroup Inc | 2024-09-30 | 2 M | Nuveen Asset Management, Llc | 2024-09-30 | 1.8 M | Clayton Dubilier & Rice Llc | 2024-09-30 | 100 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 56.2 M |
Agilon Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.41 B.Market Cap |
|
Agilon Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.14) | (0.15) | |
| Return On Capital Employed | (0.27) | (0.29) | |
| Return On Assets | (0.15) | (0.14) | |
| Return On Equity | (0.46) | (0.43) |
Determining Agilon Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Agilon Health is a good buy. For example, gross profit margin measures Agilon Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Agilon Health's profitability and make more informed investment decisions.
Evaluate Agilon Health's management efficiency
agilon health has Return on Asset of (0.0984) % which means that on every $100 spent on assets, it lost $0.0984. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.43) %, meaning that it generated no profit with money invested by stockholders. Agilon Health's management efficiency ratios could be used to measure how well Agilon Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.15. The value of Return On Capital Employed is expected to slide to -0.29. Net Tangible Assets is expected to rise to about 1.1 B this year, although the value of Total Assets will most likely fall to about 1.3 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.45 | 0.89 | |
| Tangible Book Value Per Share | 1.26 | 0.69 | |
| Enterprise Value Over EBITDA | (27.25) | (28.62) | |
| Price Book Value Ratio | 6.98 | 7.33 | |
| Enterprise Value Multiple | (27.25) | (28.62) | |
| Price Fair Value | 6.98 | 7.33 |
At agilon health, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Beta 0.602 |
Basic technical analysis of Agilon Stock
As of the 30th of January, Agilon Health shows the Semi Deviation of 7.7, downside deviation of 8.4, and Risk Adjusted Performance of 0.083. agilon health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm agilon health variance, as well as the relationship between the maximum drawdown and semi variance to decide if agilon health is priced correctly, providing market reflects its regular price of 3.59 per share. Given that Agilon Health has jensen alpha of 0.6359, we suggest you to validate agilon health's prevailing market performance to make sure the company can sustain itself at a future point.Agilon Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agilon Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agilon Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Agilon Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Agilon Health's Outstanding Corporate Bonds
Agilon Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. agilon health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Agilon bonds can be classified according to their maturity, which is the date when agilon health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| AGROSU 46 20 JAN 32 Corp BondUS00857LAA52 | View | |
| US008513AA19 Corp BondUS008513AA19 | View | |
| ADC 26 15 JUN 33 Corp BondUS008513AC74 | View | |
| ADC 2 15 JUN 28 Corp BondUS008513AB91 | View | |
| ADC 48 01 OCT 32 Corp BondUS008513AD57 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand Agilon Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Agilon Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.083 | |||
| Market Risk Adjusted Performance | 1.26 | |||
| Mean Deviation | 5.36 | |||
| Semi Deviation | 7.7 | |||
| Downside Deviation | 8.4 | |||
| Coefficient Of Variation | 1131.82 | |||
| Standard Deviation | 7.77 | |||
| Variance | 60.36 | |||
| Information Ratio | 0.0774 | |||
| Jensen Alpha | 0.6359 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0716 | |||
| Treynor Ratio | 1.25 | |||
| Maximum Drawdown | 39.93 | |||
| Value At Risk | (9.04) | |||
| Potential Upside | 11.56 | |||
| Downside Variance | 70.62 | |||
| Semi Variance | 59.24 | |||
| Expected Short fall | (5.73) | |||
| Skewness | (0.94) | |||
| Kurtosis | 5.67 |
| Risk Adjusted Performance | 0.083 | |||
| Market Risk Adjusted Performance | 1.26 | |||
| Mean Deviation | 5.36 | |||
| Semi Deviation | 7.7 | |||
| Downside Deviation | 8.4 | |||
| Coefficient Of Variation | 1131.82 | |||
| Standard Deviation | 7.77 | |||
| Variance | 60.36 | |||
| Information Ratio | 0.0774 | |||
| Jensen Alpha | 0.6359 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0716 | |||
| Treynor Ratio | 1.25 | |||
| Maximum Drawdown | 39.93 | |||
| Value At Risk | (9.04) | |||
| Potential Upside | 11.56 | |||
| Downside Variance | 70.62 | |||
| Semi Variance | 59.24 | |||
| Expected Short fall | (5.73) | |||
| Skewness | (0.94) | |||
| Kurtosis | 5.67 |
Consider Agilon Health's intraday indicators
Agilon Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Agilon Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 846690.0 | |||
| Daily Balance Of Power | 0.4848 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 3.6 | |||
| Day Typical Price | 3.59 | |||
| Price Action Indicator | 0.075 | |||
| Period Momentum Indicator | 0.16 |
Agilon Health Corporate Filings
F4 | 20th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 6th of December 2024 Other Reports | ViewVerify | |
8K | 5th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 13th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Agilon Stock media impact
Far too much social signal, news, headlines, and media speculation about Agilon Health that are available to investors today. That information is available publicly through Agilon media outlets and privately through word of mouth or via Agilon internal channels. However, regardless of the origin, that massive amount of Agilon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Agilon Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Agilon Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Agilon Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Agilon Health alpha.
Agilon Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Agilon Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
agilon health Historical Investor Sentiment
Investor biases related to Agilon Health's public news can be used to forecast risks associated with an investment in Agilon. The trend in average sentiment can be used to explain how an investor holding Agilon can time the market purely based on public headlines and social activities around agilon health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Agilon Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Agilon Health and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Agilon Health news discussions. The higher the estimate score, the more favorable the investor's outlook on Agilon Health.
Agilon Health Maximum Pain Price Across April 17th 2025 Option Contracts
Agilon Health's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Agilon Health close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Agilon Health's options.
Agilon Health Corporate Management
| Timothy Gertsch | Controller VP | Profile | |
| Benjamin Shaker | Chief Officer | Profile | |
| Bill Farry | Chief Innovation | Profile | |
| Derek Strum | Director | Profile | |
| Michelle Gourdine | Independent Director | Profile | |
| Denise Zamore | Chief Secretary | Profile |
Already Invested in agilon health?
The danger of trading agilon health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Agilon Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Agilon Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile agilon health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.76) | Revenue Per Share | Quarterly Revenue Growth 0.276 | Return On Assets |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Agilon Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.